CV Sciences, Inc. (CVSI) stock
CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-21.13%)
Close on Oct 19, 2026Market cap $2.53MP/E –Yield –
CV Sciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
CV Sciences's total debt was $0 at Sep 30, 2026. For fiscal 2025 it was $1.65M, up 143.6% from the year before. The highest annual figure on record is $3.63M in fiscal 2020.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.65M | +143.6% |
| FY2024 | Dec 31, 2024 | $677.00K | +118.4% |
| FY2021 | Dec 31, 2021 | $310.00K | -91.5% |
| FY2020 | Dec 31, 2020 | $3.63M | – |
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2018 | Dec 31, 2018 | $0 | -100.0% |
| FY2017 | Dec 31, 2017 | $850.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0 | -100.0% |
| Q2 FY2026 | Jun 30, 2026 | $18.00K | -98.5% |
| Q1 FY2026 | Mar 31, 2026 | $72.00K | -94.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.65M | +143.6% |
| Q3 FY2025 | Sep 30, 2025 | $955.00K | +208.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.23M | – |
| Q1 FY2025 | Mar 31, 2025 | $1.27M | -57.7% |
| Q4 FY2024 | Dec 31, 2024 | $677.00K | -79.3% |
| Q4 FY2021 | Dec 31, 2021 | $310.00K | -91.5% |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $3.00M | +3.2% |
| Q1 FY2021 | Mar 31, 2021 | $3.27M | – |
| Q4 FY2020 | Dec 31, 2020 | $3.63M | – |
| Q3 FY2020 | Sep 30, 2020 | $2.54M | +199.2% |
| Q2 FY2020 | Jun 30, 2020 | $2.91M | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | $850.00K | – |
See a number that looks wrong?